CRVL
CRVL
NASDAQ · Health Care

Corvel Corp

$85.91
-1.47 (-1.68%)
Financial Highlights (FY 2026)
Revenue
937.60M
Net Income
107.93M
Gross Margin
24.3%
Profit Margin
11.5%
Rev Growth
+10.1%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 24.3% 24.3% 67.6% 67.6%
Operating Margin 14.9% 13.4% 15.2% 17.6%
Profit Margin 11.5% 10.9% 13.8% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 937.60M 851.75M 770.01M 945.74M
Gross Profit 227.74M 206.89M 520.79M 639.64M
Operating Income 139.98M 114.45M 116.96M 166.22M
Net Income 107.93M 88.25M 106.52M 124.56M
Gross Margin 24.3% 24.3% 67.6% 67.6%
Operating Margin 14.9% 13.4% 15.2% 17.6%
Profit Margin 11.5% 10.9% 13.8% 13.2%
Rev Growth +10.1% +10.1% +20.4% +7.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 511.98M 499.47M
Total Equity — — 1.38B 1.30B
D/E Ratio — — 0.37 0.38
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 171.08M 147.64M 175.74M 223.10M
Free Cash Flow — — 150.62M 188.36M